Interactive Panel Discussion & Q&A: Trends & Opportunities for ctDNA in Clinical Trials

Time: 6:35 pm
day: Agenda: Optimizing Patient Selection & Prediction of Therapy Efficacy in Clinical Trials with ctDNA


• Hear biopharma and academic perspectives on key challenges in oncology drug development that ctDNA seeks to address
• Discuss how ctDNA has been used to stratify and enrich for clinical trial cohorts and support early assessment of therapy efficacy today, and how this is expected to evolve in the future
• Evaluate opportunities to leverage ctDNA to support program prioritization, secure additional funding, and optimize clinical trial design